You are not logged in.
This means
you CAN ONLY VIEW reports that were published prior to Sunday, February 25, 2024.
You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
 MIDDAY BREAKOUTS REPORT - TUESDAY, NOVEMBER 18TH, 2014
Previous Mid Day Report Next Mid Day Report >>>
|
|
DOW 17686.38 38.63 (0.22%) | NASDAQ 4700.36 29.36 (0.63%) | S&P 500 2049.78 8.46 (0.41%)
|
Time of Screening :
11/18/2014 12:00:46 PM Report Released :
11/18/2014 12:33:30 PM
Price is:
Above 52W High and Less Than 52W High
but within 12% of the 52 Week High
Volume Is:
At least 57.5% of 50 Day Average at
the time of the screening.
More details about this report...
At around
mid-way through each trading day we run
a screen against our database of
high-ranked stocks, searching for
possible buy candidates that are trading
at or near their 52-week high on above
average volume. The results of that
screen are split into the two sections
you see below. The first, titled
"TODAY's FEATURED STOCKS" shows stocks
that our experts have recently
identified as among the strongest candidates to
consider. Stocks highlighted in yellow
are the most timely and noteworthy, so
particular attention and prompt action
may be appropriate. The second section,
titled "TODAY's BREAKOUT SCREEN" shows
the remainder of stocks meeting today's
screen parameters. Our experts have
reviewed and included notes on these
stocks as well, but found that they may
not match up as favorably.
|
|
Y - Today's strongest
candidates
highlighted
by our staff
of experts.
|
|
G - Previously featured in
this report as yellow and
now may no longer be buyable
under the guidelines.
|
|
|
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(50 DAV) |
52 Wk Hi
% From Hi |
Date
Featured |
Price
Featured |
Pivot Point |
|
Max Buy |
ACT
- NASDAQ
Enact Holdings Inc
|
$261.91
|
+13.97
5.63%
|
$264.00
|
6,298,888
232.77% of 50 DAV
50 DAV is 2,706,000
|
$255.51
2.50%
|
6/20/2014 |
$216.53
|
PP = $230.87
MB = $242.41 |
Most Recent Note - 11/18/2014 12:05:49 PM
G - Hitting new 52-week highs with volume-driven gains after announcing plans to acquire Allergan (AGN) for $66 Billion. Did not form a sound new base and its color code is changed to green while getting extended from prior highs. Its 50 DMA line ($239) defines support where a violation would raise concerns.
>>> The latest Featured Stock Update with an annotated graph appeared on 11/6/2014. Click here.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
 |
Symbol - Exchange - Industry Group
Company Name |
Last |
Chg |
Day
High |
52 WK Hi |
% From Hi |
Volume
% DAV |
DAV |
AGN
- NYSE - DRUGS - Drug Manufacturers - Other
Allergan Inc
|
$212.06 |
+2.91
1.39%
|
$213.60
|
$213.91
|
-0.86% |
4,420,460
155.87%
|
2,836,000
|
Most Recent Note for AGN - 11/18/2014 12:06:16 PM
Gapped up for a new 52-week high on 11/17/14 news it will be acquired by Actavis Plc (ACT) for $66 Billion. Reported earnings +45% on +17% sales revenues for the Sep '14 quarter but prior quarterly earnings comparisons were just below the +25% minimum guideline (C criteria).
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AMBA
- NASDAQ - ELECTRONICS - Semiconductor - Specialized
Ambarella Inc
|
$51.50 |
+2.72
5.57%
|
$52.26
|
$50.47
|
2.03% |
1,475,622
73.41%
|
2,010,000
|
Most Recent Note for AMBA - 11/18/2014 12:08:00 PM
Rallying today for a new 52-week high, getting more extended from any sound base. Found support near its 50 DMA line and prior highs in the $34-36 area during its consolidation since noted in the 10/16/14 mid-day report with caution. Rallied from a previously noted bullish reverse-head-and-shoulders base but concerns were noted - "Reported earnings +42% on +25% sales revenues for the Jul '14 quarter, an improvement after Apr '14 quarter, below the +25% minimum earnings guideline (C criteria). Fundamentals have not been a match with the fact-based investment system since dropped from the Featured Stocks list on 8/21/13."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BABA
- NYSE - INTERNET - Internet Software & Services
Alibaba Group Holding Limited
|
$111.76 |
-2.49
-2.18%
|
$114.38
|
$120.00
|
-6.86% |
25,734,400
71.75%
|
35,868,000
|
Most Recent Note for BABA - 11/18/2014 12:09:23 PM
There was a "negative reversal" on 11/13/14 after it touched a new 52-week high. Very extended from any sound base after a streak of gains. Prior mid-day reports cautioned - "Reported earnings +15% on +53% sales revenues for the Sep '14 quarter, below the +25% minimum guideline (C criteria). Completed its $88 IPO on 9/19/14. Limited history is a concern."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CBPO
- NASDAQ - DRUGS - Biotechnology
China Biologic Products
|
$67.82 |
+0.70
1.04%
|
$68.28
|
$69.97
|
-3.07% |
104,412
160.63%
|
65,000
|
Most Recent Note for CBPO - 11/18/2014 12:11:35 PM
Hovering near its 52-week high, holding its ground after recent volume-driven losses. Reported earnings +45% on +30% sales revenues for the Sep '14 quarter, but fundamental concerns remain. Volume-driven gains in an impressive spurt helped it rally clear of overhead supply from a riskier "late stage" base, however prior mid-day reports repeatedly cautioned members - "Completed a new Public Offering on 6/27/14. Reported earnings +32% on +12% sales revenues for the Jun '14 quarter, but fundamental concerns remain. Earnings increases have been near or above the +25% minimum (C criteria) guideline in the 3 latest quarterly comparisons, however a downturn in FY '10 earnings is a flaw concerning the A criteria."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CVD
- NYSE - DIVERSIFIED SERVICES - Research Services
Covance Inc
|
$100.66 |
+0.20
0.20%
|
$100.87
|
$106.50
|
-5.48% |
620,279
68.16%
|
910,000
|
Most Recent Note for CVD - 11/18/2014 12:12:01 PM
Still holding its ground in a tight range since noted with caution in the 11/12/14 mid-day report - "Sub par sales revenues growth is a concern and its quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's guidelines. Perched within striking distance of its 52-week high following a considerable 11/03/14 gap up gain on news it plans to be acquired by Laboratory Corp of America (LH)."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CVI
- NYSE - ENERGY - Oil and Gas Refining and Marketing
C V R Energy Inc
|
$47.29 |
-0.51
-1.07%
|
$48.18
|
$51.44
|
-8.07% |
351,623
78.49%
|
448,000
|
Most Recent Note for CVI - 11/18/2014 12:14:45 PM
Reported a strong earnings increase for the Sep '14 quarter, but prior quarterly comparisons showed earnings increases below the +25% minimum earnings guideline (C criteria). Abrupt downturn in FY '10 earnings is a flaw concerning the A criteria, as its annual earnings history has been erratic and below the fact-based system's guidelines.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HAIN
- NASDAQ - FOOD & BEVERAGE - Processed & Packaged Goods
Hain Celestial Group
|
$108.27 |
-0.14
-0.13%
|
$109.27
|
$109.70
|
-1.30% |
344,269
59.98%
|
574,000
|
Most Recent Note for HAIN - 11/18/2014 12:17:40 PM
Perched near its 52-week high, extended from any sound base. Completed a Secondary Offering on 9/05/13. Earnings were +31% on +32% sales revenues for the Sep '14 quarter, above the +25% minimum earnings guideline (C criteria) for a 2nd quarterly comparison. Downturn in FY '09 and FY '10 earnings was noted as a flaw with respect to the A criteria.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HCA
- NYSE - HEALTH SERVICES - Hospitals
H C A Holdings Inc
|
$67.22 |
+1.49
2.27%
|
$67.96
|
$73.94
|
-9.09% |
2,803,320
67.60%
|
4,147,000
|
Most Recent Note for HCA - 11/18/2014 12:18:53 PM
Found support this week after slumping near its prior low ($62.50 on 10/15/14) defining near-term support above its 200 DMA line. Reported Sep '14 earnings +49% on +9% sales revenues and announced acquisition plans. Fundamental concerns remain as prior mid-day reports cautioned members - "Reported earnings +51% on +9% sales revenues for the Jun '14 quarter, but fundamental concerns remain. Rallied after paying out multiple Special Dividends late in 2012 and completing a 12/12/12 Secondary Offering."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HCKT
- NASDAQ - COMPUTER SOFTWARE & SERVICES - Information Technology Service
Hackett Group Inc
|
$8.22 |
+0.31
3.92%
|
$8.28
|
$8.82
|
-6.80% |
45,727
58.62%
|
78,000
|
Most Recent Note for HCKT - 11/18/2014 12:20:17 PM
Rebounding today following a volume-driven loss on the prior session retreating from its 52-week high. Technically, it broke out on 11/05/14 from a one-year base. Fundamental concerns remain, and prior mid-day reports cautioned members - "Low-priced Computer -Tech Services firm's earnings history has not been strong and steady."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
HD
- NYSE - RETAIL - Home Improvement Stores
Home Depot Inc
|
$96.04 |
-1.99
-2.03%
|
$97.71
|
$99.36
|
-3.34% |
4,341,318
73.59%
|
5,899,000
|
Most Recent Note for HD - 11/18/2014 12:22:23 PM
Reported earnings +21% on +5% sales revenues for the Oct '14 quarter. Has a new CEO as of 11/03/14. Retreating from its 52-week high with today's 3rd consecutive loss. Noted with caution in prior mid-day reports - "Reported earnings +23% on +6% sales revenues for the quarter ended July 31, 2014, and prior quarters were also below the +25% minimum earnings guideline (C criteria). Sales revenues increases in quarterly comparisons versus the year ago periods have not been especially strong, revealing no great demand for new (N criteria) products or services . Annual earnings (A criteria) increases have been improving after a downturn in FY '08 - FY '10."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
LNKD
- NYSE - INTERNET - Internet Information Providers
Linkedin Corp Class A
|
$224.12 |
+0.84
0.38%
|
$225.50
|
$239.17
|
-6.29% |
1,193,495
64.44%
|
1,852,000
|
Most Recent Note for LNKD - 11/18/2014 12:24:36 PM
Faces resistance due to overhead supply up through the $257 level. Completed a new Public Offering on 9/04/13 and went through a deep consolidation below its 200 DMA line then rebounded. Reported earnings +33% on +45% sales revenues for the Sep '14 quarter, its 2nd consecutive quarter with earnings above the +25% minimum guideline (C criteria).
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
LXFT
- NYSE - Comp Sftwr-Spec Enterprs
Luxoft Holding Inc Cl A
|
$38.92 |
-1.45
-3.59%
|
$41.35
|
$43.57
|
-10.67% |
86,562
63.65%
|
136,000
|
Most Recent Note for LXFT - 11/18/2014 12:26:03 PM
Down today for a 2nd consecutive loss, abruptly retreating after touching a new 52-week high following 5 consecutive gains on ever increasing volume. Reported earnings +23% on +28% sales revenues for the Sep '14 quarter, and fundamental concerns remain. Went through a deep consolidation below its 200 DMA line before rebounding since noted in the 2/24/14 mid-day report with caution - "Quarterly and annual earnings history (C and A criteria) has not been strong and steady."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
OILT
- NYSE - ENERGY - Oil & Gas Pipelines
Oiltanking Partners Lp
|
$48.71 |
-0.12
-0.25%
|
$49.44
|
$54.95
|
-11.36% |
122,648
86.98%
|
141,000
|
Most Recent Note for OILT - 11/18/2014 12:27:11 PM
Rebounded above its 50 DMA line with a gap up gain on 11/12/14 news it will be acquired by Enterprise Products Partners (EPD). Reported earnings +3% on +13% sales revenues for the Sep '14 quarter. Noted with caution in the 10/07/14 mid-day report - "Reported earnings +0% on +33% sales revenues for the Jun '14 quarter, below the +25% minimum earnings guideline (C criteria). Shares split 2:1 effective 7/15/14. Announced a new CEO on 3/04/14. Completed a new Public Offering on 11/19/13."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TARO
- NYSE - DRUGS - Drug Manufacturers - Other
Taro Pharmaceutical Inds
|
$149.20 |
+2.01
1.37%
|
$149.83
|
$168.99
|
-11.71% |
161,970
143.34%
|
113,000
|
Most Recent Note for TARO - 11/18/2014 12:28:21 PM
Slumped below its 50 DMA line with above average volume behind losses following a "negative reversal" on 11/10/14. Reported earnings +56% on +22% sales revenues for the Sep '14 quarter, but fundamental concerns remain. Earnings were -18% on -15% for the Jun '14 quarter, and the fact-based investment system calls for earnings strong and steady above the +25% minimum earnings guideline (C criteria). Found support above its 200 DMA line and rebounded since dropped from the Featured Stocks list on 10/10/14.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
TSN
- NYSE - FOOD & BEVERAGE - Meat Products
Tyson Foods Inc Cl A
|
$42.58 |
-0.45
-1.05%
|
$43.35
|
$44.24
|
-3.75% |
2,548,059
63.59%
|
4,007,000
|
Most Recent Note for TSN - 11/18/2014 12:30:37 PM
Nearly challenging its 52-week high today following a volume-driven gain on the prior session. Reported +24% earnings on +14% sales revenues for the Sep '14 quarter and fundamental concerns remain. The 7/28/14 mid-day report cautioned members - "Sub par sales revenues increases suggest no great demand for any new (N criteria) products or services. Annual earnings history (A criteria) is below the fact-based investment system's guidelines."
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VRX
- NYSE - DRUGS - Drug Manufacturers - Other
Valeant Pharmaceuticals
|
$141.30 |
+4.57
3.34%
|
$142.63
|
$153.10
|
-7.71% |
2,632,973
92.26%
|
2,854,000
|
Most Recent Note for VRX - 11/18/2014 12:32:13 PM
Fundamentals remain strong with earnings above the +25% minimum guideline (C criteria) through the Sep '14 quarter. Tallying its 7th consecutive gain today, working through resistance due to overhead supply up through the $153 level which may hinder upward price progress. Went through a deep consolidation below its 200 DMA line then rebounded since dropped from the Featured Stocks list on 4/04/14.
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ZTS
- NYSE - Medical-Ethical Drugs
Zoetis Inc
|
$43.72 |
-0.51
-1.15%
|
$44.94
|
$44.43
|
-1.60% |
3,262,215
68.10%
|
4,790,000
|
Most Recent Note for ZTS - 11/18/2014 12:33:09 PM
Touched another new 52-week and all-time high today then reversed into the red. Extended from any sound base following recent gains marked by volume. Reported +21% earnings on +10% sales revenues for the Sep '14 quarter. Earnings history is not a match with the fact-based investment system's fundamental guidelines (C criteria).
|
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
We are not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to FactBasedInvesting.com c/o Premium
Member Services 665 S.E. 10 Street, Suite 201
Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.
We appreciate any feedback
members may wish to send via the inquiry form
here.
|
|
|
